AbbVie Sets $80 Monthly Price for Its Vuity Eye Drug | 2021-12-13 (2024)

AbbVie has priced its new drug for age-related blurry near-vision, Vuity, at around $80 for a 30-day supply.

The drug, which in October became the first FDA-approved eye drop to treat the extremely common eye condition, is now available by prescription as an alternative to reading glasses, contact lenses or laser eye surgery.

Vuity (pilocarpine HCl ophthalmic solution) is delivered using the company’s pHast technology, which enables the therapy to adjust to the pH of the eye’s tear film. The drug works by shrinking the pupil to improve near-vision.

The condition, formally known as presbyopia, affects approximately 128 million Americans.

AbbVie Sets $80 Monthly Price for Its Vuity Eye Drug | 2021-12-13 (1)

AbbVie Sets $80 Monthly Price for Its Vuity Eye Drug | 2021-12-13 (2024)
Top Articles
Latest Posts
Article information

Author: Foster Heidenreich CPA

Last Updated:

Views: 5776

Rating: 4.6 / 5 (76 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Foster Heidenreich CPA

Birthday: 1995-01-14

Address: 55021 Usha Garden, North Larisa, DE 19209

Phone: +6812240846623

Job: Corporate Healthcare Strategist

Hobby: Singing, Listening to music, Rafting, LARPing, Gardening, Quilting, Rappelling

Introduction: My name is Foster Heidenreich CPA, I am a delightful, quaint, glorious, quaint, faithful, enchanting, fine person who loves writing and wants to share my knowledge and understanding with you.